Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tamborero

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Bioinformatics (Oxford, England)|July 26, 2013
OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genesDavid Tamborero, Abel Gonzalez-Perez, Nuria Lopez-Bigas
Plos One|February 15, 2013
Oncodrive-CIS: a method to reveal likely driver genes based on the impact of their copy number changes on expressionDavid Tamborero, Nuria Lopez-Bigas, Abel Gonzalez-Perez
Genome Medicine|October 8, 2016
Rational design of cancer gene panels with OncoPaDCarlota Rubio-Perez, Jordi Deu-Pons, David Tamborero, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 3, 2008
Cooled-tip vs. 8 mm-tip catheter for circumferential pulmonary vein ablation: comparison of efficacy, safety, and lesion extensionMaria Matiello, Lluis Mont, David Tamborero, et al.
Bioinformatics (Oxford, England)|August 28, 2014
OncodriveROLE classifies cancer driver genes in loss of function and activating mode of actionMichael P Schroeder, Carlota Rubio-Perez, David Tamborero, et al.
Journal of Internal Medicine|May 3, 2024
High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyondAnders Edsjö, Hege G Russnes, Janne Lehtiö, et al.
Pacing and Clinical Electrophysiology : PACE|September 20, 2006
Anodal capture in cardiac resynchronization therapy implications for device programmingDavid Tamborero, Lluis Mont, Roberto Alanis, et al.
The American Journal of Cardiology|April 26, 2008
Fate of left atrial function as determined by real-time three-dimensional echocardiography study after radiofrequency catheter ablation for the treatment of atrial fibrillationVictoria Delgado, Bàrbara Vidal, Marta Sitges, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 3, 2009
Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablationTom De Potter, Antonio Berruezo, Lluis Mont, et al.
European Heart Journal|June 3, 2009
Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trialJose M Tolosana, Paola Berne, Lluis Mont, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Bioinformatics (Oxford, England)|July 26, 2013
OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genesDavid Tamborero, Abel Gonzalez-Perez, Nuria Lopez-Bigas
Plos One|February 15, 2013
Oncodrive-CIS: a method to reveal likely driver genes based on the impact of their copy number changes on expressionDavid Tamborero, Nuria Lopez-Bigas, Abel Gonzalez-Perez
Genome Medicine|October 8, 2016
Rational design of cancer gene panels with OncoPaDCarlota Rubio-Perez, Jordi Deu-Pons, David Tamborero, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 3, 2008
Cooled-tip vs. 8 mm-tip catheter for circumferential pulmonary vein ablation: comparison of efficacy, safety, and lesion extensionMaria Matiello, Lluis Mont, David Tamborero, et al.
Bioinformatics (Oxford, England)|August 28, 2014
OncodriveROLE classifies cancer driver genes in loss of function and activating mode of actionMichael P Schroeder, Carlota Rubio-Perez, David Tamborero, et al.
Journal of Internal Medicine|May 3, 2024
High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyondAnders Edsjö, Hege G Russnes, Janne Lehtiö, et al.
Pacing and Clinical Electrophysiology : PACE|September 20, 2006
Anodal capture in cardiac resynchronization therapy implications for device programmingDavid Tamborero, Lluis Mont, Roberto Alanis, et al.
The American Journal of Cardiology|April 26, 2008
Fate of left atrial function as determined by real-time three-dimensional echocardiography study after radiofrequency catheter ablation for the treatment of atrial fibrillationVictoria Delgado, Bàrbara Vidal, Marta Sitges, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 3, 2009
Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablationTom De Potter, Antonio Berruezo, Lluis Mont, et al.
European Heart Journal|June 3, 2009
Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trialJose M Tolosana, Paola Berne, Lluis Mont, et al.
Pageof 7